Brief: Citius Oncology Expands Lymphir Distribution To Turkey And Middle East Countries
04/12/2025 13:44
Dec 4 (Reuters) - Citius Oncology Inc CTOR.O: CITIUS ONCOLOGY EXPANDS LYMPHIR™ DISTRIBUTION TO TURKEY AND MIDDLE EAST COUNTRIES THROUGH EXCLUSIVE AGREEMENT WITH ER-KIM CITIUS ONCOLOGY INC - ER-KIM TO BE EXCLUSIVE DISTRIBUTOR OF LYMPHIR IN TURKEY AND GCC Source text: ID:nPn6M6zmWa Further company coverage: CTOR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules